Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/27542
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBenjathum N.
dc.contributor.authorAdam A.
dc.contributor.authorMekseepralard C.
dc.contributor.authorRungsiwiwut R.
dc.contributor.authorJariyapongskul A.
dc.date.accessioned2022-12-14T03:17:35Z-
dc.date.available2022-12-14T03:17:35Z-
dc.date.issued2022
dc.identifier.issn1252208
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85123378924&doi=10.35755%2fjmedassocthai.2022.S01.00158&partnerID=40&md5=8c021ae98f46ed9f78671ef3dfaf11f3
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/27542-
dc.description.abstractBackground: The increased accumulation of advanced glycation end products (AGEs) under diabetes conditions can promote oxidative stress and inflammation in vasculature and contribute to endothelial dysfunction. Naringin, a flavonoid compound that occurs naturally in citrus fruits, has been shown to have anti-diabetic and anti-oxidant properties. Objective: To investigate the efficacy of naringin in the improvement of diabetes-induced leukocyte adhesion to cerebral endothelium through AGEs-RAGE-NF-κB pathway. Materials and Methods: Six-week-old Sprague-Dawley were divided into three groups; normal group (CON: n=8), type 2 diabetes group (DM2: n=8), and type 2 diabetes group with naringin supplementation (DM2-NG: n=8). Rats were fed with high-fat diet for four weeks, followed by a single STZ injection to induce type 2 diabetes. Naringin was supplemented daily by oral gavage feeding (50 mg/kg BW). Twelve weeks after STZ injection with or without naringin supplementation, fasting blood glucose (FBG), serum insulin and calculated homeostatic model assessment of insulin resistance (HOMA-IR) were examined. Leukocyte adhesion at post-capillary venule was carried out by using intravital fluorescence microscopy. AGEs, RAGE and TNF-α were detected by ELISA whereas NF-κB, ICAM-1 were investigated using Western blot analysis and MDA was determined by TBARs assay. Results: After 12 weeks of naringin feeding into DM2-NG rats, the FBG levels decreased 62.8% compared to those without supplementation. Moreover, the β-cell function was improved by reducing serum insulin levels and HOMA-IR. Not only the endothelial function was improved by reducing the number of leukocyte adhesion, but the expression of ICAM-1 was also decreased. Naringin supplementation also attenuated inflammation and oxidative stress by reducing the levels of AGEs, RAGE, and its downstream molecules, NF-κB-TNF-α. Conclusion: It is suggested that supplementation with naringin in type 2 diabetes rat model can reduce leukocyte adhesion to vascular endothelium via anti-hyperglycemic, anti-oxidant and anti-inflammatory effects through AGEs-RAGE-NF-κB-TNF-α-ICAM-1 signaling pathway. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
dc.languageen
dc.subjectadvanced glycation end product
dc.subjectadvanced glycation end product receptor
dc.subjectantidiabetic agent
dc.subjectantioxidant
dc.subjectaurantiin
dc.subjectintercellular adhesion molecule 1
dc.subjectmalonaldehyde
dc.subjectpentobarbital
dc.subjectpolyvinylidene fluoride
dc.subjectstreptozocin
dc.subjectthiobarbituric acid reactive substance
dc.titleNaringin Attenuates Leukocyte Adhesion to Cerebral Endothelium in Type 2 Diabetic Rats
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 105, No. (2022), p.S115-S123
dc.identifier.doi10.35755/jmedassocthai.2022.S01.00158
Appears in Collections:Scopus 2022

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.